Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Collaboration Live has received expansion of its U.S. Food & Drug Administration 510(k) market clearance for remote diagnostic use on additional mobile platforms. Available on Philips Ultrasound Systems EPIQ and Affiniti , Collaboration Live allows clinicians to collaborate in real-time with colleagues in order to complete image acquisition and diagnosis regardless of location.
Ultrasound imaging is one of the most accessible and low-cost imaging modalities. However, capturing and interpreting the acquired images and making an accurate diagnosis requires a great deal of expertise and skill. While ultrasound equipment is readily available both in hospitals and healthcare settings, widespread staffing shortages can impede access to care. In addition, the COVID-19 pandemic highlighted the risk to clinicians in contact with infectious patients, and the resulting backlog of postponed exams is now increasing workloads and driving the need for greater efficiency. Collaboration Live enables remote diagnosis, expanding the ability to image patients inside and outside of healthcare facilities, and could help limit the risk of exposure for healthcare workers and patients to infectious diseases such as COVID-19.
With its expanded clearance for diagnostic use on additional platforms, clinicians now have the ability to consult or diagnose from their mobile device, check the strength of their bandwidth before making a call, and check their remote screen calibration to ensure image quality is appropriate for diagnosis. This can enable greater efficiency and flexibility for clinicians since they are no longer limited to a PC for remote collaboration.
Collaboration Live is already helping to extend access to quality care in underserved settings. "We have been able to open a strictly telemedicine office to serve our patients in rural communities because Collaboration Live enables us to carry out a full diagnostic patient visit remotely,” said Michael S. Ruma, MD, MPH, at Perinatal Associates of New Mexico, who will present peer-reviewed data on the associated return-on-investment at this year’s American Institute of Ultrasound in Medicine Annual Meeting (AIUM 2022).